<< North Carolina Biotechnology Center establishes Research Triangle Park headquarters | Survey reveals that hand-washing behaviors are poor despite H1N1 swine flu >>
Read in | English | Norsk

Hypercholesterolemia therapy area pipeline report from Research and Markets

Published on September 10, 2009 at 6:54 AM · No Comments

Research and Markets (http://www.researchandmarkets.com/research/9f0a24/hypercholesterolem) has announced the addition of the "Hypercholesterolemia Therapy Area Pipeline Report" report to their offering.

Life Science Analytics, Hypercholesterolemia Therapy Area Pipeline Report contains detailed information on the hypercholesterolemia drug pipeline. This report provides insight into the pipeline status of hypercholesterolemia drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

Key Topics Covered:

% of Products by Phase of Development No. of Products by Phase of Development Marketed Products vs. Pipeline Products Company Overview - Pipeline Projects Legend Patent Expirations Upcoming Milestones Product Sales Full Pipeline View News Updates

Source: Life Science Analytics

Posted in: Pharmaceutical News

Tags:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading